RED
YEAST RICE, STATINS & CHOLESTEROL
According to the
American Heart Association, more than 50 million Americans require some
sort of
intervention to prevent or treat coronary artery disease, and another
15
million, or more, require medication in order to lower their
cholesterol levels
to a safer range.
Today, the statin
class of drugs plays a dominant role in the management of elevated
cholesterol
(hyperlipidemia), and these drugs are widely used to both prevent and
treat
coronary artery disease when diet and exercise prove inadequate by
themselves. While
the full spectrum and extent of the
health benefits of statin drugs continues to be the subject of debate,
there is
ample high-level clinical research evidence that statins significantly
reduce
the risk of clinically significant coronary artery disease, heart
attack
(myocardial infarction), and death in patients with elevated blood
levels of “bad
cholesterol” (LDL), and even in patients who have normal LDL levels,
but who
also have elevated C-reactive protein (CRP) levels. (CRP
is a protein that becomes elevated in the
blood in the presence of inflammation.)
Unfortunately, as
with all medications, the statins are associated with potentially
significant
side effect. The
most serious side
effects that have been associated with statin drugs are muscle injury
(rhabdomyolysis) and liver injury.
Based
upon recent research data, approximately 5 percent of patients taking
statin
drugs will experience significant muscle pain and weakness, requiring
that they
discontinue their statin medication.
In
severe cases, rhabdomyolysis can lead to permanent muscle injury and
kidney
failure. An
additional 2 percent of patients
may have to stop taking statins due to significant liver toxicity. Joint pain, peripheral
nerve injury, and
memory loss have also been associated with the use of some statin
drugs,
although the link between statins and these more uncommon side effects
is less
clear than for rhabdomyolysis and liver injury.
When diet and
exercise alone fail to reduce elevated LDL levels, particularly when
there is a
personal or family history of cardiovascular disease, statins are
generally the
first line of treatment (in addition to aspirin, if there are no
contraindications to taking aspirin).
However, patients who do not tolerate statins have limited
choices in
terms of effective alternative lipid-lowering therapy.
Niacin, which is
one of the oldest forms of therapy for hyperlipidemia, is one
alternative option
, and although not as effective as statins, this vitamin supplement,
when given
in high enough doses, can not only reduce LDL cholesterol, but also
triglycerides (the predominant form of fat in the blood) as well. Additionally, niacin
therapy can also raise
the “good cholesterol” (HDL) level in the blood. (By
comparison, statins have only small
effects on triglyceride levels, and minimal effects on HDL levels in
the
blood.) The biggest
disadvantage of
niacin therapy, however, is its tendency to cause severe flushing in
about half
of patients who take the standard form of this drug, as well as the
abdominal
pain, nausea and vomiting that occurs in another 8 to 10 percent of
patients. However,
newer extended-release preparations
of niacin are much better tolerated, with an incidence of adverse side
effects
of approximately 6 to 8 percent.
(Fortunately, in most cases, flushing and the other
adverse side effects
associated with niacin therapy will improve over time if patients
continue to
take this medication.) As
with statin
drugs, however, there is a 1 or 2 percent risk of liver toxicity
associated
with niacin therapy for hyperlipidemia, and most patients who take
either
statin drugs or niacin for elevated LDL levels should be periodically
monitored
for elevations of liver enzymes in their blood.
Long-term niacin therapy may also increase blood sugar
(glucose) levels
in patients with pre-diabetes or diabetes, and may also raise blood
levels of
uric acid, which may, in turn, lead to the development of gout in
susceptible
individuals. Therefore,
fasting blood
glucose levels and the level of uric acid in the blood should be
monitored, as
well, in patients who are taking niacin for hyperlipidemia (these two
latter complications
of niacin therapy also appear to be less common when taking the newer
extended-release niacin preparations.)
Other non-statin
therapies are also available for the treatment of elevated LDL and
triglyceride
levels, but they are seldom used, as they are not only less effective
than
statins and niacin, but their side effects profiles are so significant
that
very few patients remain compliant with these alternative
lipid-lowering therapies.
Red yeast rice (Monascus
purpureus, for you
botanists out there), has been used in China for at least 1,200 years. The yeast spores are
typically grown on rice,
from which this product gains its name.
In addition to its use, for centuries, as an herbal
medication (mostly
in East Asia) for stomach complaints and poor circulation, Chinese food
lovers will
recognize the brick-red color of red yeast rice whenever they eat
Peking duck
or char siu.
A handful of small previous research studies have suggested that red
yeast rice may be as effective as some statins in reducing LDL and
triglyceride
levels when taken as a dietary supplement.
This is not surprising, as most pure preparations of red
yeast rice
actually contain naturally-occurring lovastatin, one of the early
statin drugs
(and which, by the way, was first isolated from aspergillus, which is
another
form of fungus). However,
other
compounds contained within red yeast rice are also thought to
additively contribute
to the claimed LDL-lowering effects of this dietary supplement, above
and
beyond the contribution of the small amount of lovastatin contained
within many
of these preparations.
A new prospective, randomized, placebo-controlled clinical research
study of red yeast rice strongly suggests that at least some forms of
red yeast
rice supplements may, indeed, be highly effective in reducing elevated
blood
levels of LDL in patients who have been unable to tolerate standard
statin
medications. This
study, which appears
in the current volume of the Annals of Internal Medicine,
randomized 31
patients to receive 1,800 milligrams of red yeast rice twice per day,
while the
other 31 patients in this study received placebo (sugar) pills that
looked
identical to the red yeast rice supplement pills.
Neither the patients nor the researchers knew
which patients were receiving the red yeast rice and which patients
were
receiving the placebo pills until after the study was completed. All 62 patients were also
enrolled in a 12-week
lifestyle and dietary modification program for patients with
hyperlipidemia.
This study was continued for 24 weeks, and blood levels of LDL, HDL,
triglycerides, and liver enzymes were measured at the beginning of the
study,
as well as 12 weeks and 24 weeks into the study.
Additionally, blood levels of creatinine
phosphokinase (CPK), a muscle enzyme that is released when
statin-induced
rhabdomyolysis occurs, were also measured at these same time points. (All of these 62 patients
had previously discontinued
statin therapy due to muscle pain.)
At the 12-week point, the average LDL levels of the patients in the red
yeast rice group had declined by a very significant 43 milligrams per
deciliter
(mg/dl), compared to the 11 mg/dl reduction obtained in the placebo
group with
lifestyle and diet modification alone.
At the 24-week point, a 35 mg/dl reduction in LDL levels
was observed in
the red yeast rice group versus a 15 mg/dl average decrease in LDL
levels at 24
weeks in the placebo pill group. (It
is
very important to note, by the way, that even the “placebo group” of
hyperlipidemia patients were able to reduce their elevated LDL levels
with diet
and exercise alone!)
While LDL and total cholesterol levels were significantly reduced in
the
red yeast rice group, when compared to the patients in the placebo
group, blood
levels of HDL, triglycerides, liver enzymes, and CPK did not differ
between the
two groups of patients. Moreover,
there
were also no significant differences in weight loss or the incidence of
muscle
pain between the two patient groups following 24 weeks of red yeast
rice
supplementation.
In summary, this was a small prospective, randomized,
placebo-controlled clinical research study involving patients who had
previously discontinued statin therapy due to muscle toxicity. In this study, which
lasted for a relatively
short duration of about 6 months, red yeast rice supplementation (in
addition
to lifestyle and dietary modifications) significantly reduced blood
levels of
LDL and total cholesterol. Throughout
this research study, there was no clinical or laboratory evidence of
liver or
muscle toxicity associated with the use of red yeast rice supplements.
The results of this study are highly intriguing, although it does leave
some important questions unanswered.
In
particular, it is not clear to what extent that naturally-occurring
lovastatin,
contained within in the red yeast rice supplement used in this study,
is
responsible for the LDL-lowering effects of red yeast rice that were
observed
in this study (a small previous research study has suggested, but not
proven,
that the degree of LDL reduction observed with red yeast rice
supplementation
is greater than what would be predicted by the actual lovastatin
content of red
yeast rice).
Despite the very intriguing results of this small pilot study, all
readers
should be reminded of some very important caveats regarding the
purchase and use
of red yeast rice supplements. Because
of the variable but significant lovastatin content of many red yeast
rice
dietary supplements, the Food and Drug Administration (FDA) has
recently sent
warning letters to several dietary supplement manufacturers, indicating
the
Government’s concern that red yeast rice contains a known
prescription-only
drug and, therefore, that the FDA’s position is that such supplements
should
probably not be sold as over-the-counter dietary supplements. The variability of
lovastatin content in
various forms of red yeast rice also makes it difficult for consumers
to know
how much lovastatin is contained within these supplements, which may be
a
problem for patients who are predisposed to liver, muscle, or kidney
toxicity
associated with statin use. Also,
because lovastatin, and other potentially active compounds in red yeast
rice, can
pass into both the placenta and breast milk, women who are pregnant (or
who may
be pregnant), and women who are breastfeeding, should not be exposed to
any supplement
or foods that contain red yeast rice.
Finally, other compounds that may be toxic to the liver
and kidneys have
previously been detected in some red yeast rice preparations.
Because of
these various health-related concerns, I want to make it very clear
that I am
not, at this time, advocating the routine use of red yeast rice for
medicinal
purposes. However, if you have failed
all
other forms of lifestyle, dietary, and medical therapy for significant
hyperlipidemia, then you may wish to forward a link to this column to
your
Internist or Cardiologist. If
they are
open to the possibility of incorporating red yeast rice into your
lipid-lowering regimen, and they are willing to closely monitor you for
signs
of toxicity (as well as unexpected pregnancy, for fertile female
patients),
then this approach may be something that you and your doctor may wish
to
consider. However, I absolutely do not
recommend that you begin taking red
yeast rice supplements without the involvement and approval of your
physician,
because of the health-related safety concerns that I have already
discussed.
Disclaimer: As always, my advice to readers is to seek the advice of your physician before making any significant changes in medications, diet, or level of physical activity
(Anticipated Publication Date: March 2010)
(Click above image for TV36 interview of Dr. Wascher)
Share:
Links to Other Health & Wellness Sites
Copyright 2009.
Robert A. Wascher, MD, FACS.
All rights reserved.
Dr.
Wascher's Archives: